Primary cutaneous follicle centre lymphoma natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Primary cutaneous follicle centre lymphoma}} Please help WikiDoc by adding content here. It's easy! Click here to learn about edit...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Primary cutaneous follicle centre lymphoma}} | {{Primary cutaneous follicle centre lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | |||
==Overview== | |||
==Prognosis== | |||
* Spread from the skin is unusual, and the [[prognosis]] is excellent<ref name="Jaffe_2011_1"/>{{rp|218}} with a 5-year survival of over 97%.<ref name="Jaffe_2011_1"/>{{rp|314}} | |||
* The International Extranodal Lymphoma Study Group identified three prognostic factors, that are used to assess a cutaneous lymphoma international prognostic index (CLIPI), which is [[prognosis|prognostic]] of disease-free status.<ref name="Wilcox2015"/> | |||
:* Elevated [[Lactate dehydrogenase|LDH]] | |||
:* More than two skin lesions | |||
:* Nodular lesions | |||
==References== | ==References== |
Revision as of 13:57, 2 March 2016
Primary cutaneous follicle centre lymphoma Microchapters |
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary cutaneous follicle centre lymphoma natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
FDA on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
CDC on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
Primary cutaneous follicle centre lymphoma natural history, complications and prognosis in the news |
Blogs on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Prognosis
- Spread from the skin is unusual, and the prognosis is excellent[1]:218 with a 5-year survival of over 97%.[1]:314
- The International Extranodal Lymphoma Study Group identified three prognostic factors, that are used to assess a cutaneous lymphoma international prognostic index (CLIPI), which is prognostic of disease-free status.[2]
- Elevated LDH
- More than two skin lesions
- Nodular lesions